Skip to main content
logo
Enorama Pharma AB (publ) (STO:ERMA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.175
+0.445 (60.96%)
Oct 15, 2026, 3:36 PM CET

Enorama Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
8814220311428171
Market Cap Growth
-48.91%-29.89%77.51%308.04%-83.60%-12.51%
Enterprise Value
8613619410827171
Last Close Price
0.731.913.362.512.9517.98

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
37.6352.0112.8984.294.1015.50
PB Ratio
--6.0726.045.860.898.01
P/TBV Ratio
--26.045.860.898.01

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
36.1849.6212.3079.673.8815.53

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---0.020.060.18
Net Debt / Equity Ratio
0.040.13-0.27-0.29-0.07-0.39
Net Debt / EBITDA Ratio
0.040.050.070.140.050.32
Net Debt / FCF Ratio
0.040.050.060.140.070.28
Asset Turnover
0.090.230.630.030.140.24
Inventory Turnover
2.492.731.551.483.666.03
Quick Ratio
0.120.180.430.800.681.77
Current Ratio
0.210.251.871.270.951.92
Return on Equity (ROE)
---320.44%-174.74%-158.97%-239.87%
Return on Assets (ROA)
-213.34%-321.44%-75.83%-62.91%-52.64%-37.20%
Return on Capital Employed (ROCE)
211.30%264.90%-390.90%-173.10%-115.60%-69.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-109.61%-52.74%-21.56%-38.97%-149.82%-16.22%
FCF Yield
-97.43%-41.60%-17.57%-36.12%-117.48%-17.67%
Buyback Yield / Dilution
-21.21%-30.99%-91.50%-253.96%-26.23%-11.44%